SEC Form 4 · accession 0001493152-17-007631
Ernexa Therapeutics Inc. · ERNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory Matthew Thomas
Director
Period of report
Jul 7, 2017
Accepted (ET)
Jul 10, 2017 · 8:43 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000748592
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $6.62 | Jul 7, 2017 | A | 600 | A | Jul 7, 2017 | Jul 6, 2027 | Common Stock | 600 | 600 | D |
Explanation of responses
- F1Stock option granted under the NTN Buzztime, Inc. Amended 2010 Performance Incentive Plan. One half of these options are immediately vested and exercisable. The remaining options vest and become exercisable in 12 equal monthly installments from the date of grant.